Clinical Trial Update: Study of Sirolimus-Coated BX VELOCITY Balloon-Expandable Stent in Treatment of de Novo Native Coronary Artery Lesions (SIRIUS) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial SIRIUS evaluating a sirolimus-coated BX VELOCITY stent for de novo native coronary artery lesions has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Sirolimus-coated BX VELOCITY Balloon-Expandable Stent (sirolimus-coated stent)

Snippet

Sponsor: Cordis US Corp. | Conditions: Coronary Artery Disease | Phase 3 | Status: COMPLETED